Availability will vary by state, and a pharmacy professor says cost barriers can keep families from getting vaccinated.
|Articles|April 30, 2021
Coronavirus News Roundup: John Legend Joins Walgreens Campaign, Opportunities for Pharmacists in Clinical Trials
Here’s a roundup of the latest coronavirus-related news.
Advertisement
With all Americans over 16 years able to get vaccinated for COVID-19 and the
“This Is Our Shot” campaign aims to promote COVID-19 vaccination, address vaccine hesitancy, and acknowledge the disproportionately higher infection rates among Black communities.
The future of clinical trials in a post pandemic world will rely on a patient-centered approach. Pharmacists can play a role to caring for these patients.
A committee of vaccine advisers to the CDC convened to discuss the risk of a rare blood clotting condition linked to the Johnson & Johnson COVID-19 vaccine.
Identifying “Silent” COVID-19 Infections Reduces Disease Burden in Kids
With the COVID-19 vaccine still not authorized for use in most of the pediatric population, reducing infection in children is important and identifying asymptomatic and presymptomatic infections could be key.
Advertisement
Related to this article
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
Pharmacist pain clinics typically focus on comprehensive medication management involving the entire patient scenario.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.
In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.
Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.
In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.
Advertisement
Advertisement
Trending on Drug Topics
1
From Binder to Action: Making Infectious Disease Outbreak Plans Operational
2
Retatrutide Delivers 20.8% Weight Loss in Adults With Type 2 Diabetes
3
Diabetes Medication Adherence Lags for Black and Hispanic Medicare Patients
4
Independent Pharmacies Remain Resilient, Essential Community Providers | NCPA 2026
5